Kintz Samuel

Enliven Therapeutics, Inc. · PRESIDENT AND CEO

Kintz Samuel is listed in filings as PRESIDENT AND CEO at Enliven Therapeutics, Inc.. This profile follows SEC Form 4 activity through Nov 19, 2025, including sale activity. Recent filings connect the profile to Enliven Therapeutics, Inc. (ELVN). The current snapshot covers public activity from Jun 27, 2024 to Nov 19, 2025. Reported amounts are shown as $272.7K to $74.2K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.

History Trades

Company	Value	Action	Price	Last Price
Enliven Therapeutics, Inc.ELVN	$267k12.5k shares	SellOct 17, 2025	$21.33	$53.20
Enliven Therapeutics, Inc.ELVN	$74k3.7k shares	SellSep 26, 2025	$20.06	$53.20
Enliven Therapeutics, Inc.ELVN	$56k2.8k shares	SellSep 23, 2025	$20.03	$53.20
Enliven Therapeutics, Inc.ELVN	$20k1k shares	SellSep 19, 2025	$20.25	$53.20
Enliven Therapeutics, Inc.ELVN	$95k5k shares	SellSep 17, 2025	$19.09	$53.20
Enliven Therapeutics, Inc.ELVN	$30k1.5k shares	SellAug 20, 2025	$20.00	$53.20
Enliven Therapeutics, Inc.ELVN	$12k590 shares	SellAug 19, 2025	$20.00	$53.20
Enliven Therapeutics, Inc.ELVN	$208k10.4k shares	SellAug 18, 2025	$20.02	$53.20
Enliven Therapeutics, Inc.ELVN	$106k4.7k shares	SellJul 17, 2025	$22.69	$53.20
Enliven Therapeutics, Inc.ELVN	$90k4.2k shares	SellJul 17, 2025	$21.58	$53.20
Enliven Therapeutics, Inc.ELVN	$86k3.7k shares	SellJul 17, 2025	$23.37	$53.20
Enliven Therapeutics, Inc.ELVN	$232k10.5k shares	SellJun 17, 2025	$22.08	$53.20
Enliven Therapeutics, Inc.ELVN	$45k2k shares	SellJun 17, 2025	$22.75	$53.20
Enliven Therapeutics, Inc.ELVN	$150k7.5k shares	SellJun 3, 2025	$20.05	$53.20
Enliven Therapeutics, Inc.ELVN	$82k5k shares	SellMay 19, 2025	$16.49	$53.20
Enliven Therapeutics, Inc.ELVN	$43k2.2k shares	SellMay 2, 2025	$20.00	$53.20
Enliven Therapeutics, Inc.ELVN	$107k5.3k shares	SellMay 1, 2025	$20.08	$53.20
Enliven Therapeutics, Inc.ELVN	$82k5k shares	SellApr 17, 2025	$16.42	$53.20
Enliven Therapeutics, Inc.ELVN	$260k12.5k shares	SellMar 17, 2025	$20.83	$53.20
Enliven Therapeutics, Inc.ELVN	$28k924 shares	SellOct 18, 2024	$30.00	$53.20
Enliven Therapeutics, Inc.ELVN	$390k13.9k shares	SellOct 9, 2024	$28.07	$53.20
Enliven Therapeutics, Inc.ELVN	$81k2.8k shares	SellOct 9, 2024	$28.53	$53.20
Enliven Therapeutics, Inc.ELVN	$368k13.2k shares	SellOct 8, 2024	$27.95	$53.20
Enliven Therapeutics, Inc.ELVN	$2.9k100 shares	SellOct 8, 2024	$28.51	$53.20
Enliven Therapeutics, Inc.ELVN	$75k2.7k shares	SellOct 7, 2024	$27.50	$53.20
Enliven Therapeutics, Inc.ELVN	$336k12.2k shares	SellOct 4, 2024	$27.51	$53.20
Enliven Therapeutics, Inc.ELVN	$14k526 shares	SellOct 1, 2024	$27.54	$53.20
Enliven Therapeutics, Inc.ELVN	$275k12k shares	SellAug 26, 2024	$22.89	$53.20
Enliven Therapeutics, Inc.ELVN	$63k2.3k shares	SellJul 31, 2024	$27.56	$53.20
Enliven Therapeutics, Inc.ELVN	$205k8.2k shares	SellJul 25, 2024	$25.10	$53.20
Enliven Therapeutics, Inc.ELVN	$1.1k43 shares	SellJul 25, 2024	$25.83	$53.20
Enliven Therapeutics, Inc.ELVN	$93k3.8k shares	SellJul 25, 2024	$24.53	$53.20
Enliven Therapeutics, Inc.ELVN	$247k11.4k shares	SellJun 25, 2024	$21.63	$53.20
Enliven Therapeutics, Inc.ELVN	$13k578 shares	SellJun 25, 2024	$22.30	$53.20